By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Pain Pressure Threshold (PPT)
Summary
What it measures:
Pain pressure threshold (PPT) is used to measure deep muscular tissue sensitivity. The test determines the amount of pressure over a given area in which a steadily increasing nonpainful pressure stimulus turns into a painful pressure sensation. A varying pressure is applied from 0.5 to 1 kg/sec in a perpendicular direction relative to the muscle. PPT has no standard protocol on administration and placement. Equipment used varies with many handheld electric algometers.
PPT has been used on a wide variety of patients and conditions, including musculoskeletal and neuromuscular disorders (eg, Parkinson disease, tension headaches, pelvic pain, low back pain, myofascial trigger points, sacroiliac joint pain, knee osteoarthritis, skin humidity, shoulder pain, lateral epicondylitis). This summary contains information on use of PPT testing in patients or clients with many varied diagnoses, conditions, and disabilities.1-27
ICF Domain
Body structure function of the many areas.
ICF Categories
Other PT/OT subsequent limitation
Taskforce Recommendations:
A clinical practice guideline for neck and low back pain recommends the use of PPT to quantify pain levels. (29) Breast Cancer EDGE highly recommends PPT in those with breast cancer. They recommend clinicians should decide the use of PPT depending on how they want to assess pain and whether to use a unidimensional or multidimensional tool. PPT is a unidimensional pain outcome tool because it measures the intensity of pain, without the quality or impact of pain. (30)
Clinical Insights:
PPT is a quick, objective measure used to quantify pain intensity and requires minimal to no training. Since minimal training is typical, those administering should be cautious to apply the algometer at the set rate recommended by the manufacturer. Since the technique is easy to perform, PPT may be a useful tool for quantifying pain, which allows researchers and clinicians to monitor treatment effects. (21) However, there are several potential limitations that could result in some clinicians not adopting the test, including the lack of formal training, normative values, and a standardized protocol. Pain is also easily quantifiable with other measures, such as the Visual Analog Scale.
Members Only Content
Join APTA to get unlimited access to content including evidence-based research, guidance on payment changes, and other resources to help you thrive. Learn more about membership benefits.
Already a member? Log in
Date: September 8, 2020
Contact: practice@apta.org
Content Type: Test & Measure
Leanna O’Hora, SPT; Erica Robbins, ATC, SPT; Logan Savidge, SPT; Brittney Tokarick, SPT; Brandt Wood, SPT; Mary Ann Holbein-Jenny, PT, DPT, PhD
Edessa Bello-Rapoport, PT, MBA Aimee Bosley, PT
You Might Also Like...
CPG
Role of Physical Therapists in the Management of Individuals at Risk for or Diagnosed With Venous Thromboembolism: Evidence-Based Clinical Practice Guideline 2022 (CPG+)May 13, 2022
This update of a 2016 guideline provides assistance to physical therapists in the decision-making process when treating patients at risk for venous thromboembolism
CPG
Vestibular Rehabilitation for Peripheral Vestibular Hypofunction: An Updated Clinical Practice Guideline From the Academy of Neurologic Physical Therapy of the American Physical Therapy Association (CPG+)Apr 1, 2022
Updated guidelines on how to optimize rehabilitation outcomes for persons with peripheral vestibular hypofunction undergoing vestibular rehabilitation.
CPG
Physical Therapist Management of Parkinson Disease: A Clinical Practice Guideline from the American Physical Therapy Association (CPG+)Apr 1, 2022
Related Resources Parkinson Disease CPG Toolkit Pocket Guide Podcast: Parkinson CPG Knowledge Translation CPG+ Appraisal Rating 6 out of 7 (How was this